Active hemicellulose compound

Drug Profile

Active hemicellulose compound

Alternative Names: Active hexose correlated compound; AHCC

Latest Information Update: 01 May 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Charles R. Drew University of Medicine and Science; Daiwa Pharmaceutical
  • Developer Charles R. Drew University of Medicine and Science
  • Class Antineoplastics; Hexoses
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Cancer

Most Recent Events

  • 05 Sep 2002 Clinical trials in Cancer in Japan (PO)
  • 16 Jul 1999 A clinical study has been added to the therapeutic trials section
  • 07 Sep 1998 A preclinical study has been added to the pharmacodynamics section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top